{"schema_version":"secwatch.filing_event.v1","accession":"0001378325-26-000026","form_type":"8-K","ticker":"CV","cik":"0001378325","company_name":"CapsoVision, Inc","filed_at":"2026-07-02T20:10:05+00:00","discovered_at":"2026-07-02T20:11:00.532509+00:00","generated_at":"2026-07-02T20:11:13.725840+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"CapsoVision appoints Dr. David Shields to board; Dr. Imperial resigns but remains consultant","bullets":["Dr. David Shields, a gastroenterologist with 40+ years experience and capsule endoscopy pioneer, appointed Class I director and Compensation Committee member effective July 1, 2026.","Dr. Joanne Imperial resigned as director effective July 1, 2026; no disagreement with management or board.","Dr. Imperial will continue as independent consultant at $600/hour, up to 5 hours/week, and received option for 10,000 shares vesting over 4 years.","Dr. Shields will provide clinical consulting at $600/hour, up to 3 hours/week, under a separate consulting agreement.","Dr. Imperial to advise on pancreatic cancer program and planned 2027 esophageal varices study using next-gen capsule platform."],"urls":{"canonical":"https://secwatch.observer/filing/0001378325-26-000026","json":"https://secwatch.observer/filing/0001378325-26-000026.json","markdown":"https://secwatch.observer/filing/0001378325-26-000026.md","text":"https://secwatch.observer/filing/0001378325-26-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/0001378325-26-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/cv-20260701.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:11:13.725840+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01bc45eeba","claim":"Dr. David S. Shields was appointed as Class I director at CapsoVision, Inc.","evidence_excerpt":"On July 1, 2026, the Board of Directors (the “Board”) of CapsoVision Inc. (the “Company”) appointed Dr. David Stanley Shields to serve as a Class I director of the Board and as a member of the Compensation Committee of the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/0001378325-26-000026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"},{"claim_id":"52e70b0e50","claim":"Dr. Joanne Imperial departed as Class I director at CapsoVision, Inc.","evidence_excerpt":"On July 1, 2026, Dr. Joanne Imperial stepped down from the Board as a Class I director and as a member of the Compensation Committee of the Board, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1378325/000137832526000026/0001378325-26-000026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Class I director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}